* ALIX *
2002 - Alsace
Strasbourg-Illkirch
www.alix-pharma.com Discovery, Drugs
(also Design, Protein)
Key words: NHR (Nuclear Hormone Receptors), Ligands, Protein crystallography, Cancer, Type II diabetes, Obesity, Early-stage
Mission: to discover, from early-stage, drugs based structure-based design using X-ray crystallography, with a main interest in nuclear hormone receptors, for cancers, type II diabetes, obesity and other metabolic diseases, also for neglected diseases such as schistosomiases, and to provide third parties with service activities in protein crystallization protein crystallography, and ligand screening using mass spectrometry
Clients: Research labs
info@alix-pharma.com
Age: 7 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS | | Spin-off |
Managing Dir.-CEO: Zeyer (Denis) [born 1972, Ph.D., ex-IGBMC]
Sc.Dir.-CSO: Zeyer (Denis)
Fin.Dir.-CFO:
BusDev:
Financers (Hist.): privately owned (registered capital 2006 = 0.07 M€)
Note: Alix has become, end of 2008, a subsidiary of Novalix | Turnover (M€) : 0.5 (2006)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Multiple
Position : Preclin
Company confirm : none |
History | DATE | MILESTONE | TYPE | TIME | | 2008 .12 | Partnering R&D agreement with Sosho, an Osaka university spin-off, for protein structure determination of intractable targets | R&D | [6 years] |
| 2008 .10 | Acquisition of Novalix (by merger and integration), a contract research biotech company (60 employees) specialised in protein production and cristallography analysis | ACQ+ | [5 years] |
| 2008 .09 | Nomination : Denis Zeyer, new CEO, replacing Jean-Paul Renaud, back to academic activities | ORGN | [5 years] |
| 2002 .11 | Company founded by Jean-Paul Renaud, Jean Cavarelli, Dino Moras, Olivier Poch, Marc Ruff, Jean-Claude Thierry, Jean-Marie Wurtz, and Marat Yusupov, as a spin-off from the Department of Structural Biology and Genomics (DBGS) of the Institute of Genetics and Molecular and Cellular Biology (IGBMC) | ORGF | [0 year] | Actualisation / Updating: 23-Feb-2009 |
|
